Luigi Manenti

Luigi Manenti serves as CMO at Alentis Therapeutics. Alentis Therapeutics operates in the pharmaceuticals sector with approximately 64.0 employees. Alentis Therapeutics generates annual revenue of 1000000.0. To date, Alentis Therapeutics has raised 365600000.0 in total funding, with the most recent round being Series D.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Google Font API WordPress.org Mobile Friendly Basis Circle

claudin1 cldn1 claudin oncology cancer kidney fibrosis rare diseases nephrology lung fibrosis liver fibrosis alef02 drug development drug discovery pulmonology hepatology fibrosis antibodydrug conjugates adc hnscc idiopathic pulmonary fibrosis ancaassociated vasculitis alep02 alep03 lixudebart pharmaceutical manufacturing claudin-1 monoclonal antibodies antibody-drug conjugates adcs solid tumors cancer therapy r&d pipeline clinical development tumor targeting immune checkpoint blockade first-in-class biotechnology fda fast track designation human clinical trials jacques lacan's constructs cancer immunotherapy therapeutic target exposed claudin-1 tumor microenvironment extracellular matrix remodeling pharmaceutical development oncology drug development fibrotic signaling renal diseases preclinical programs t-cell engagers anticancer antibody biologic drugs pharmaceutical pipelines personalized medicine cancer biomarkers tumor microenvironment studies biopharma clinical-stage biotech targeted therapies neoplastic diseases research & development fdaind clearance lean development biotherapeutics cancer care clinical trials industries pipeline phase 1/2 trials clinical candidate anti-claudin-1 therapies cancer treatment fibrosis reversal squamous cancers organ fibrosis clinical-stage biotechnology innovative biopharmaceuticals precision medicine unmet medical needs patient populations advanced liver fibrosis anca-associated vasculitis therapeutic potential biotechnology industry pharmaceutical industry fibrotic diseases proprietary technology platform first-in-class therapies clinical operations basel switzerland patient demographics healthcare providers clinical trial participants partnerships funding series d financing competitive landscape hospital & health care pharmaceuticals medical health care health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

How can I contact Luigi Manenti?

Luigi Manenti's verified email address is available on MessageCEO. They currently work at Alentis Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Luigi Manenti lead?

Luigi Manenti is CMO at Alentis Therapeutics, a company in the pharmaceuticals sector with 64.0 employees.

What industry is Luigi Manenti in?

Luigi Manenti works in the pharmaceuticals industry as CMO at Alentis Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Luigi Manenti's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Luigi Manenti's profile is kept up-to-date with the latest available information.

Last updated: April 7, 2026